Anti-Alzheimer’s Disease activity: In vitro AChE inhibitory activity3: IC50 = 44.0 μMBerberine (positive control): IC50 = 0.1 μM. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.